Islet Sciences, Inc. seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Islet Sciences is traded on the OTCPK under the ticker symbol ISLT.
Islet Sciences, Inc. is focused on improving patient outcomes by developing new medicines and technologies for the treatment of metabolic diseases. The Company’s pipeline includes small molecule therapeutics, cell therapy based artificial pancreas, and a molecular diagnostic to detect the onset of insulin dependent diabetes.